ALKS

Alkermes plc News Headlines

$44.73
*  
0.25
0.56%
Get ALKS Alerts
*Delayed - data as of Aug. 29, 2014  -  Find a broker to begin trading ALKS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog
8/26/2014 7:00:00 PM - Zacks.com

Sector Update: Health-Care Shares Flat Pre-Market
8/26/2014 8:48:38 AM - MT Newswires

Sector Update: Health Care
8/26/2014 8:47:46 AM - MT Newswires

ADXS Makes It Big, ALKS Waiting To Face FDA, ITMN Snapped Up, KITE Flies High
8/26/2014 12:52:00 AM - RTT News

Alkermes Submits NDA To FDA For Schizophrenia Treatment Aripiprazole Lauroxil
8/25/2014 7:17:00 AM - RTT News

Thursday's ETF Movers: BBH, GXC
8/14/2014 3:52:33 PM - BNK Invest

Drug Patent Expirations This Week: UCB, Roche's Genentech
8/8/2014 9:17:00 AM - Seeking Alpha

Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
8/4/2014 3:40:00 PM - Zacks.com

Alkermes Reports Q2 Non-GAAP EPS Of $0.11; Updates FY14 Guidance
7/31/2014 7:30:00 AM - RTT News

Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog
7/30/2014 12:04:00 PM - Zacks.com

Alkermes' Pipeline Development Impresses, Key Updates Ahead - Analyst Blog
7/21/2014 4:40:00 PM - Zacks.com

Alkermes Begins Phase 1 Study Of ALKS 8700 For Treatment Of Multiple Sclerosis
7/17/2014 7:37:00 AM - RTT News

Alkermes plc (ALKS) Jumps: Stock Rises 5.7% - Tale of the Tape
6/23/2014 9:21:00 AM - Zacks.com

Alkermes' Aripiprazole Lauroxil Looks Promising - Analyst Blog
6/19/2014 11:40:00 AM - Zacks.com

Sector Update: Healthcare
6/18/2014 8:55:02 AM - MT Newswires

Sector Update: Healthcare Shares Flat Pre-Market; Pfizer Teams with Cellectis on Immunotherapy
6/18/2014 8:51:02 AM - MT Newswires

Biotech Stocks Get Turbo Boost From Idenix Deal
6/11/2014 6:45:00 PM - Seeking Alpha

Alkermes Progresses with its Late Stage Candidate - Analyst Blog
6/11/2014 5:00:00 PM - Zacks.com

Alkermes To Present At Goldman Sachs Conference; Webcast At 5:40 PM ET
6/10/2014 3:01:00 PM - RTT News

Alkermes' Pipeline Holds Promise - Analyst Blog
6/6/2014 4:30:00 PM - Zacks.com

Alkermes To Present At Jefferies Healthcare Conference; Webcast At 11:00 AM ET
6/2/2014 10:00:00 AM - RTT News

Wider-than-expected Loss at Alkermes, Revenues Slip - Analyst Blog
5/1/2014 11:50:01 AM - Zacks.com

Sector Update: Healthcare
4/30/2014 8:54:36 AM - MT Newswires

Sector Update: Healthcare Shares Mixed Pre-Market; WellPoint up 2% on Q1 Results
4/30/2014 8:51:51 AM - MT Newswires

Xenoport's Path Is Long, But The Potential Is There
4/17/2014 8:31:00 PM - Seeking Alpha